iShares Biotech ETF -2.1%
Biotech weakness often reflects rate sensitivity and risk-appetite shifts in long-duration equities.
https://finance.yahoo.com/quote/IBB
Finnence → https://finnence.tailbf979f.ts.net/story/78909?ref=farcaster
Terminus needs JavaScript to show replies and pictures.